OUTDOOR ACTION LTD

Company number 03774678 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Here is a comprehensive financial health assessment for OUTDOOR ACTION LTD, applying a diagnostic approach to the company's financial data.

1. Financial Health Score: B-

Explanation: The company possesses a very strong underlying constitution, evidenced by robust net assets and consistent turnover. However, it has been assigned a B- due to a sharp decline in profitability in the latest fiscal year and a highly congested balance sheet where liquidity is heavily tied up in inventory. The patient is generally healthy but is exhibiting acute symptoms of margin pressure and potential cash flow blockages.

2. Key Vital Signs

  • Heart Rate (Turnover): £3,537,411. The company's revenue is remarkably stable, showing only a slight decrease from the previous year (£3.56M). This indicates a steady customer base and consistent demand for its outdoor products.
  • Blood Pressure (Operating Profit): £45,050. This is a significant drop from £171,723 in 2024. Operating margin has fallen from 4.8% to just 1.3%. This sudden drop is a clear symptom of financial stress, primarily driven by rising overheads rather than falling sales.
  • Cholesterol Levels (Stock/Inventory): £1,916,463. Inventory makes up a staggering 94% of the company's current assets and represents roughly 54% of annual turnover. This is an unusually high concentration, suggesting either deliberate overstocking or slow-moving goods that are clogging the company's financial arteries.
  • Immune System (Net Assets/Equity): £1,677,497. The company has an excellent reserve of retained earnings. This strong equity base means the business is highly resilient to shocks and is not at risk of insolvency.
  • Blood Flow (Cash & Quick Ratio): £84,315. While cash has improved from £43k last year, the "quick ratio" (cash plus debtors divided by current liabilities) is roughly 0.2. This means the company cannot meet its short-term liabilities (£576k) without selling its stock.

3. Diagnosis

The financial data reveals a business with a robust skeletal structure but suffering from a sudden fever in operating costs. While gross profit margins remain acceptable at 25% (down only slightly from 26%), administrative expenses surged by over 11% (£85,000 increase), severely impacting the bottom line.

The most critical diagnosis is the heavy reliance on inventory. The balance sheet shows £1.9 million tied up in stock. While the current ratio (current assets vs. current liabilities) looks very healthy at 3.5, this is an illusion created by the inventory. If the company were unable to sell this stock quickly, it would face an immediate cash flow crisis. The business is essentially asset-rich but cash-poor, relying on the continuous, rapid turnover of inventory to keep the lights on.

4. Recommendations

To restore full financial wellness, the following treatment plan is recommended:

  1. Inventory Decongestion: Conduct an urgent, granular review of the £1.9M stock holding. Identify slow-moving, seasonal, or obsolete items. Implement targeted clearance strategies to convert this stagnant stock into working capital, easing the pressure on cash flow.
  2. Overhead Reduction Diet: Investigate the £85,000 spike in administrative expenses. Scrutinize all overhead categories to identify unnecessary expenditures, renegotiate supplier contracts, and return administrative costs to historical levels.
  3. Margin Protection Therapy: When clearing excess inventory, be cautious of aggressive discounting that could further erode the 25% gross margin. Focus on value-added promotions or bundling to maintain profitability while moving stock.
  4. Cash Flow Monitoring: Implement a strict 13-week rolling cash flow forecast. Given the low quick ratio, management must have a clear, daily view of cash inflows and outflows to ensure liabilities are met on time without relying on further stock accumulation.

Perspective: Financial Health Diagnostician · Model: glm-5.2 · Generated 6 October 2026